Skip to main content

News Releases

Get News Alerts by RSS (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
06/06/2023
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
06/04/2023
Puma Biotechnology Announces Presentation of Biomarker Findings from a Phase II Study of Alisertib with Paclitaxel versus Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer at the 2023 ASCO Annual Meeting
05/05/2023
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
05/04/2023
Puma Biotechnology Reports First Quarter Financial Results
04/20/2023
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2023 Financial Results
04/11/2023
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
03/14/2023
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology
03/03/2023
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
03/02/2023
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results
02/28/2023
Puma Biotechnology to Participate in a Panel Discussion at Cowen’s 43rd Annual Health Care Conference
02/16/2023
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results
02/07/2023
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
02/01/2023
Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Breast Cancer with a HER2 Mutation
01/12/2023
Puma Biotechnology to Present at B. Riley Securities’ 3rd Annual Oncology Conference
01/11/2023
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
01/09/2023
Puma Biotechnology Releases Updated Corporate Presentation